Search Within

Stephen Solomon

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (12)
  2. Meeting Abstract (11)
Groups
  1. Center for Pancreatic Cancer Research (23)
  2. Interventional Radiology Service (23)
  3. Molecular Pharmacology and Chemistry Program Faculty (23)
  4. Radiology, Department of (23)
  5. Sloan Kettering Institute Faculty (23)
  6. GSK Faculty (21)

More Groups

People
  1. Steven Larson (12)
  2. Howard Scher (9)
  3. Jorge Carrasquillo (9)
  4. Michael Morris (9)
  5. Jason Lewis (8)
  6. Jeremy Durack (7)

More People

Years
  1. 2021 (1)
  2. 2019 (4)
  3. 2018 (3)
  4. 2016 (1)
  5. 2015 (5)
  6. 2014 (5)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. European Journal of Nuclear Medicine and Molecular Imaging (2)
  3. Radiology (2)
  4. Annals of Surgical Oncology (1)
  5. BJU International (1)
  6. Bioelectrochemistry (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. Springer (4)
  3. American Association for Cancer Research (3)
  4. Radiological Society of North America, Inc. (2)
  5. American Medical Association (1)
  6. Cell Press (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Electroporation-induced changes in tumor vasculature and microenvironment can promote the delivery and increase the efficacy of sorafenib nanoparticles
    Journal Article

    Kodama, H.; Shamay, Y.; Kimura, Y.; Shah, J.; Solomon, S. B.; Heller, D.; Srimathveeravalli, G.
    Bioelectrochemistry (2019)

    Fulltext@MSK | Save
  • Electroporation enhances delivery and effectiveness of sorafenib nanoparticles for the treatment of colorectal cancer
    Meeting Abstract

    Kodama, H.; Shamay, Y.; Shah, J.; Heller, D.; Solomon, S.; Srimathveeravalli, G.
    Journal of Vascular and Interventional Radiology (2019)

    Fulltext@MSK | Save
  • Particle counting autoradiography of radioactive biopsy specimens
    Meeting Abstract

    Seiter, D.; Miller, B.; Fung, E.; Cheal, S.; Maitrejean, S.; Zanzonico, P.; Larson, S.; Solomon, S.; Humm, J. L.; Furenlid, L. R.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2018)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy - A preliminary report
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M.; Rusch, V.; O'Cearbhaill, R.; Ngai, D.; Chintala, N.; Halton, E.; Diamonte, C.; Modi, S.; Solomon, S.; more...
    Molecular Therapy (2018)

    Fulltext@MSK | Save
  • Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer
    Journal Article

    Fox, J. J.; Gavane, S. C.; Blanc-Autran, E.; Nehmeh, S.; Gonen, M.; Beattie, B.; Vargas, H. A.; Schoder, H.; Humm, J. L.; Fine, S. W.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Nonthermal ablation by using intravascular oxygen radical generation with WST11: Dynamic tissue effects and implications for focal therapy
    Journal Article

    Kimm, S. Y.; Tarin, T. V.; Monette, S.; Srimathveeravalli, G.; Gerber, D.; Durack, J. C.; Solomon, S. B.; Scardino, P. T.; Scherz, A.; Coleman, J.
    Radiology (2016)

    Fulltext@MSK | Save
  • A phase I/II study for analytic validation of 89Zr-J591 immunoPET as a molecular imaging agent for metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Durack, J. C.; Lyashchenko, S. K.; Cheal, S. M.; Beylergil, V.; Lefkowitz, R. A.; Carrasquillo, J. A.; Martinez, D. F.; Fung, A. M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save